96 related articles for article (PubMed ID: 1878011)
1. Effect of probucol on triglyceride turnover in streptozotocin-diabetic rats.
Yoshino G; Matsushita M; Maeda E; Nagata K; Morita M; Matsuba K; Tani T; Horinuki R; Kimura Y; Kazumi T
Atherosclerosis; 1991 May; 88(1):69-75. PubMed ID: 1878011
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term administration of probucol on triglyceride turnover in rats.
Yoshino G; Matsushita M; Maeda E; Nagata K; Naka Y; Murata Y; Hirano T; Kazumi T
Coron Artery Dis; 1994 Jan; 5(1):67-72. PubMed ID: 8136934
[TBL] [Abstract][Full Text] [Related]
3. Effect of mild diabetes and dietary fructose on very-low-density lipoprotein triglyceride turnover in rats.
Yoshino G; Matsushita M; Iwai M; Morita M; Matsuba K; Nagata K; Maeda E; Furukawa S; Hirano T; Kazumi T
Metabolism; 1992 Mar; 41(3):236-40. PubMed ID: 1542260
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term insulin deficiency and insulin treatment on the composition of triglyceride-rich lipoproteins and triglyceride turnover in rats.
Yoshino G; Matsushita M; Maeda E; Naka Y; Nagata K; Morita M; Matsuba K; Kazumi T; Kasuga M
Atherosclerosis; 1992 Feb; 92(2-3):243-50. PubMed ID: 1632852
[TBL] [Abstract][Full Text] [Related]
5. Plasma lipoproteins in streptozotocin-diabetic rats, after Triton WR-1339 treatment.
Takahashi K; Murase T; Yamada N; Iwamoto Y; Akanuma Y; Takaku F
Horm Metab Res; 1984 Dec; 16 Suppl 1():82-4. PubMed ID: 6532938
[TBL] [Abstract][Full Text] [Related]
6. Effect of probucol on plasma clearance and organ uptake of chylomicrons and VLDLs in normal and diabetic rats.
Mamo JC; Elsegood CL; Umeda Y; Hirano T; Redgrave TG
Arterioscler Thromb; 1993 Feb; 13(2):231-9. PubMed ID: 8381300
[TBL] [Abstract][Full Text] [Related]
7. Effect of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on triglyceride kinetics in chronically streptozotocin-diabetic rats.
Maeda E; Yoshino G; Matsushita M; Nagata K; Morita M; Murata Y; Naka Y; Kazumi T
Metabolism; 1993 Jan; 42(1):52-7. PubMed ID: 8446048
[TBL] [Abstract][Full Text] [Related]
8. Hypertriglyceridemia in nephrotic rats is due to a clearance defect of plasma triglyceride: overproduction of triglyceride-rich lipoprotein is not an obligatory factor.
Yoshino G; Hirano T; Nagata K; Maeda E; Naka Y; Murata Y; Kazumi T; Kasuga M
J Lipid Res; 1993 Jun; 34(6):875-84. PubMed ID: 8354953
[TBL] [Abstract][Full Text] [Related]
9. Effect of dietary fructose on triglyceride turnover in streptozotocin-diabetic rats.
Yoshino G; Iwai M; Kazumi T; Matsushita M; Morita M; Matsuba K; Iwatani I; Baba S
Atherosclerosis; 1989 Sep; 79(1):41-6. PubMed ID: 2803345
[TBL] [Abstract][Full Text] [Related]
10. MDL 29311, an analog of probucol, decreases triglycerides in rats by increasing hepatic clearance of very-low-density lipoprotein.
Sheetz MJ; Barnhart RL; Jackson RL; Robinson KM
Metabolism; 1994 Feb; 43(2):233-40. PubMed ID: 8121308
[TBL] [Abstract][Full Text] [Related]
11. Hypertriglyceridemia in the diabetic rat. Defective removal of serum very low density.
Van Tol A
Atherosclerosis; 1977 Jan; 26(1):117-28. PubMed ID: 189777
[TBL] [Abstract][Full Text] [Related]
12. Effects of vanadate on plasma lipoprotein profiles in experimental diabetic rats.
Sekar N; Govindasamy S
Biochem Int; 1991 Mar; 23(5):935-40. PubMed ID: 1883401
[TBL] [Abstract][Full Text] [Related]
13. Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the rat.
Strandberg T; Kuusi T; Tilvis R; Miettinen TA
Atherosclerosis; 1981; 40(3-4):193-201. PubMed ID: 7332600
[TBL] [Abstract][Full Text] [Related]
14. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
Kalaiarasi P; Kaviarasan K; Pugalendi KV
Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of probucol and insulin on cataracts of diabetic rats fed a high cholesterol diet.
Yoshida M; Kimura H; Kyuki K; Ito M
Eur J Pharmacol; 2005 Apr; 513(1-2):159-68. PubMed ID: 15869753
[TBL] [Abstract][Full Text] [Related]
16. Effect of probucol on recovery from streptozotocin diabetes in rats.
Yoshino G; Matsushita M; Maeda E; Morita M; Nagata K; Matsuba K; Tani T; Horinuki R; Kimura Y; Kazumi T
Horm Metab Res; 1992 Jul; 24(7):306-9. PubMed ID: 1516883
[TBL] [Abstract][Full Text] [Related]
17. Effects of probucol on impaired cardiac performance and lipid metabolism in streptozotocin-induced diabetic rats.
Tada H; Oida K; Kutsumi Y; Shimada Y; Nakai T; Miyabo S
J Cardiovasc Pharmacol; 1992 Aug; 20(2):179-86. PubMed ID: 1381008
[TBL] [Abstract][Full Text] [Related]
18. [Changes in serum lipid and lipoproteins in alloxan-diabetic rats--studies for one year].
Arisue K; Uchida K; Takeuchi N
Jikken Dobutsu; 1994 Apr; 43(2):217-26. PubMed ID: 8174623
[TBL] [Abstract][Full Text] [Related]
19. Acute probucol treatment partially restores vasomotor activity and abnormal lipid metabolism whereas morphological changes are not affected in aorta from long-term STZ-diabetic rats.
Karasu C
Exp Clin Endocrinol Diabetes; 1998; 106(3):189-96. PubMed ID: 9710359
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
